Ascend Laboratories, LLC recalls Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem La…
- Recall date
- April 27, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0547-2026
- FDA classification
- Class II
- Brand / firm
- Ascend Laboratories, LLC
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.
Get recall alerts
Free email alert whenever Ascend Laboratories, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ascend Laboratories, LLC